C. Marcos

Tobramycin inhalation powder (TOBI Podhaler®) for the treatment of lung infection in patients with cystic fibrosis

E. Zamora, J. Ancochea, C. Cisneros, 2016, Expert review of anti-infective therapy.

SARS-CoV-2 Viremia Precedes an IL6 Response in Severe COVID-19 Patients: Results of a Longitudinal Prospective Cohort

I. González-Álvaro, C. Muñoz‐Calleja, L. Cardeñoso, 2022, Frontiers in Medicine.

IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study

T. Cavero, F. Sánchez‐Madrid, I. González-Álvaro, 2020, Journal of Allergy and Clinical Immunology.

Relevant SARS‐CoV‐2 viremia is associated with COVID‐19 severity: Prospective cohort study and validation cohort

J. Ancochea, C. Suárez Fernández, R. García-Vicuña, 2022, Journal of medical virology.

Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients

F. Sánchez‐Madrid, I. González-Álvaro, M. Orts, 2021, Scientific Reports.

Obstructive sleep apnea: The key for a better asthma control?

E. Zamora, J. Eiros, P. Landete, 2022, Sleep medicine.

ABO blood group as a determinant of COVID-19 and Long COVID: An observational, longitudinal, large study

X. Busquets, J. Ancochea, C. Valenzuela, 2023, PloS one.

Occurrence of SARS-CoV-2 viremia is associated with genetic variants of genes related to COVID-19 pathogenesis

I. González-Álvaro, C. Muñoz‐Calleja, L. Cardeñoso, 2023, Frontiers in medicine.

Tobramycin inhalation powder (TOBI Podhaler®) for the treatment of lung infection in patients with cystic fibrosis

E. Zamora, E. Vázquez-Espinosa, C. Marcos, 2016, Expert review of anti-infective therapy.